- Home
- PACK vs RNAC Comparison
PACK vs RNAC Comparison
Compare PACK & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACK
- RNAC
- Stock Information
- Founded
- PACK 1972
- RNAC 2007
- Country
- PACK United States
- RNAC United States
- Employees
- PACK N/A
- RNAC N/A
- Industry
- PACK Containers/Packaging
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- PACK Consumer Discretionary
- RNAC Health Care
- Exchange
- PACK Nasdaq
- RNAC Nasdaq
- Market Cap
- PACK 313.3M
- RNAC 276.3M
- IPO Year
- PACK N/A
- RNAC 2016
- Fundamental
- Price
- PACK $5.29
- RNAC $10.05
- Analyst Decision
- PACK Buy
- RNAC Strong Buy
- Analyst Count
- PACK 3
- RNAC 4
- Target Price
- PACK $7.17
- RNAC $40.00
- AVG Volume (30 Days)
- PACK 1.3M
- RNAC 48.4K
- Earning Date
- PACK 08-05-2025
- RNAC 08-07-2025
- Dividend Yield
- PACK N/A
- RNAC N/A
- EPS Growth
- PACK N/A
- RNAC N/A
- EPS
- PACK N/A
- RNAC N/A
- Revenue
- PACK $380,700,000.00
- RNAC $1,026,000.00
- Revenue This Year
- PACK $10.14
- RNAC N/A
- Revenue Next Year
- PACK $7.92
- RNAC N/A
- P/E Ratio
- PACK N/A
- RNAC N/A
- Revenue Growth
- PACK 10.38
- RNAC N/A
- 52 Week Low
- PACK $2.91
- RNAC $8.46
- 52 Week High
- PACK $8.70
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- PACK 67.12
- RNAC 34.71
- Support Level
- PACK $5.02
- RNAC $10.50
- Resistance Level
- PACK $6.31
- RNAC $11.80
- Average True Range (ATR)
- PACK 0.33
- RNAC 0.56
- MACD
- PACK 0.10
- RNAC -0.11
- Stochastic Oscillator
- PACK 55.24
- RNAC 0.45
About PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.